Clinical Trial Update: Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 sustainable and efficient platform trial for developing therapies in early breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Nagoya City University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING